| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelial Cells | 48 | 2024 | 3702 | 3.840 |
Why?
|
| Mammary Glands, Human | 17 | 2024 | 202 | 3.530 |
Why?
|
| Mammary Glands, Animal | 7 | 2023 | 273 | 2.290 |
Why?
|
| Receptor, erbB-2 | 20 | 2021 | 2606 | 2.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 9 | 2016 | 615 | 1.810 |
Why?
|
| Protein-Tyrosine Kinases | 46 | 2010 | 2433 | 1.660 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 10 | 2021 | 1408 | 1.580 |
Why?
|
| bcl-X Protein | 6 | 2024 | 412 | 1.560 |
Why?
|
| Cell Culture Techniques | 10 | 2021 | 1667 | 1.430 |
Why?
|
| Oncogenes | 9 | 2017 | 1236 | 1.350 |
Why?
|
| Breast Neoplasms | 38 | 2024 | 21188 | 1.330 |
Why?
|
| Cell Proliferation | 26 | 2023 | 10486 | 1.310 |
Why?
|
| Organoids | 5 | 2024 | 745 | 1.290 |
Why?
|
| Proto-Oncogene Proteins | 32 | 2022 | 4528 | 1.260 |
Why?
|
| src-Family Kinases | 14 | 2012 | 539 | 1.260 |
Why?
|
| Cell Transformation, Neoplastic | 24 | 2014 | 2848 | 1.260 |
Why?
|
| Spheroids, Cellular | 5 | 2020 | 331 | 1.210 |
Why?
|
| Aniline Compounds | 4 | 2024 | 1095 | 1.170 |
Why?
|
| Cell Adhesion | 30 | 2016 | 3102 | 1.160 |
Why?
|
| Cell Movement | 17 | 2015 | 5216 | 1.110 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2020 | 379 | 1.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2024 | 8664 | 1.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 17 | 2020 | 2884 | 1.050 |
Why?
|
| Epithelium | 8 | 2020 | 1607 | 1.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 11 | 2016 | 2911 | 1.030 |
Why?
|
| Neoplasm Metastasis | 9 | 2020 | 4926 | 1.030 |
Why?
|
| Ovarian Neoplasms | 11 | 2019 | 4919 | 1.020 |
Why?
|
| Apoptosis | 19 | 2021 | 9527 | 1.020 |
Why?
|
| Immunoconjugates | 4 | 2023 | 976 | 0.990 |
Why?
|
| Phosphoproteins | 21 | 2016 | 2452 | 0.990 |
Why?
|
| Tyrosine | 39 | 2016 | 1427 | 0.980 |
Why?
|
| Protein Kinases | 26 | 2011 | 1611 | 0.950 |
Why?
|
| Breast | 14 | 2024 | 1976 | 0.950 |
Why?
|
| Myosin Type II | 4 | 2012 | 71 | 0.950 |
Why?
|
| Neoplasms | 25 | 2024 | 22389 | 0.940 |
Why?
|
| Signal Transduction | 61 | 2020 | 23653 | 0.940 |
Why?
|
| Morphogenesis | 11 | 2011 | 747 | 0.940 |
Why?
|
| Extracellular Matrix | 9 | 2017 | 1739 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2020 | 2460 | 0.930 |
Why?
|
| TOR Serine-Threonine Kinases | 7 | 2020 | 2063 | 0.920 |
Why?
|
| Anoikis | 6 | 2009 | 49 | 0.910 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 23 | 2003 | 147 | 0.900 |
Why?
|
| Integrins | 16 | 2004 | 843 | 0.900 |
Why?
|
| Sulfonamides | 4 | 2024 | 1981 | 0.880 |
Why?
|
| Cell Line, Tumor | 45 | 2023 | 17173 | 0.870 |
Why?
|
| Phosphorylation | 71 | 2016 | 8317 | 0.860 |
Why?
|
| BRCA1 Protein | 3 | 2024 | 1156 | 0.850 |
Why?
|
| Avian Sarcoma Viruses | 20 | 1992 | 76 | 0.840 |
Why?
|
| Cadherins | 7 | 2016 | 906 | 0.830 |
Why?
|
| Haploinsufficiency | 1 | 2024 | 334 | 0.820 |
Why?
|
| Cell Polarity | 6 | 2018 | 639 | 0.800 |
Why?
|
| Oncogene Protein pp60(v-src) | 24 | 2005 | 75 | 0.780 |
Why?
|
| MAP Kinase Signaling System | 6 | 2019 | 1495 | 0.780 |
Why?
|
| Cell Survival | 15 | 2021 | 5793 | 0.770 |
Why?
|
| Genes, src | 12 | 2005 | 51 | 0.740 |
Why?
|
| Oxidative Stress | 6 | 2021 | 3139 | 0.730 |
Why?
|
| Cell Communication | 6 | 2020 | 1660 | 0.730 |
Why?
|
| Tumor Microenvironment | 7 | 2022 | 3952 | 0.720 |
Why?
|
| Adherens Junctions | 3 | 2016 | 90 | 0.700 |
Why?
|
| Cell Transformation, Viral | 22 | 1993 | 530 | 0.690 |
Why?
|
| Cell Line | 42 | 2018 | 15604 | 0.680 |
Why?
|
| Animals | 142 | 2024 | 169335 | 0.670 |
Why?
|
| Enzyme Precursors | 8 | 2002 | 166 | 0.660 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 3 | 2010 | 94 | 0.650 |
Why?
|
| Cytokinesis | 3 | 2019 | 170 | 0.640 |
Why?
|
| Epidermal Growth Factor | 12 | 2020 | 697 | 0.640 |
Why?
|
| Models, Biological | 22 | 2020 | 9499 | 0.640 |
Why?
|
| Clone Cells | 4 | 2021 | 1670 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2013 | 314 | 0.630 |
Why?
|
| Mesoderm | 4 | 2014 | 679 | 0.620 |
Why?
|
| Blood Platelets | 19 | 2003 | 2479 | 0.620 |
Why?
|
| Neoplasm Proteins | 6 | 2020 | 3608 | 0.620 |
Why?
|
| Drug Resistance, Neoplasm | 9 | 2022 | 5342 | 0.610 |
Why?
|
| Cues | 1 | 2023 | 878 | 0.610 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 737 | 0.590 |
Why?
|
| Antioxidants | 3 | 2021 | 1673 | 0.580 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2020 | 693 | 0.570 |
Why?
|
| beta Catenin | 3 | 2023 | 1047 | 0.570 |
Why?
|
| Cytoskeletal Proteins | 5 | 2018 | 1328 | 0.560 |
Why?
|
| Platelet Membrane Glycoproteins | 10 | 2001 | 283 | 0.550 |
Why?
|
| Viral Proteins | 28 | 1992 | 1802 | 0.540 |
Why?
|
| alpha Catenin | 1 | 2016 | 37 | 0.530 |
Why?
|
| Glutathione | 1 | 2019 | 589 | 0.530 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2016 | 71 | 0.530 |
Why?
|
| Protein Kinase Inhibitors | 10 | 2024 | 5707 | 0.520 |
Why?
|
| Protein Interaction Mapping | 2 | 2017 | 621 | 0.520 |
Why?
|
| Gene Expression Regulation | 15 | 2020 | 11932 | 0.510 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1356 | 0.490 |
Why?
|
| Cell Lineage | 4 | 2021 | 2576 | 0.490 |
Why?
|
| Stromal Cells | 1 | 2020 | 1337 | 0.490 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2023 | 3621 | 0.480 |
Why?
|
| rho GTP-Binding Proteins | 5 | 2008 | 279 | 0.470 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 58 | 0.460 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2019 | 480 | 0.460 |
Why?
|
| Cytoskeleton | 14 | 2011 | 1179 | 0.460 |
Why?
|
| Mice | 51 | 2024 | 82072 | 0.460 |
Why?
|
| Antineoplastic Agents | 11 | 2021 | 13698 | 0.450 |
Why?
|
| Humans | 154 | 2024 | 768970 | 0.450 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2024 | 11886 | 0.430 |
Why?
|
| Focal Adhesions | 2 | 2011 | 114 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 998 | 0.420 |
Why?
|
| Fibroblasts | 11 | 2020 | 4179 | 0.420 |
Why?
|
| Thrombin | 9 | 1996 | 600 | 0.420 |
Why?
|
| Phagocytosis | 3 | 2008 | 1530 | 0.410 |
Why?
|
| Profilins | 1 | 2012 | 65 | 0.410 |
Why?
|
| Enzyme Activation | 18 | 2014 | 3588 | 0.410 |
Why?
|
| Autophagy | 4 | 2013 | 1351 | 0.410 |
Why?
|
| Neoplasms, Experimental | 3 | 2016 | 1231 | 0.410 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 755 | 0.400 |
Why?
|
| Acrylic Resins | 1 | 2012 | 135 | 0.400 |
Why?
|
| Membrane Glycoproteins | 2 | 2018 | 3713 | 0.400 |
Why?
|
| Guanine Nucleotide Exchange Factors | 4 | 2006 | 572 | 0.390 |
Why?
|
| Research Personnel | 3 | 2012 | 590 | 0.380 |
Why?
|
| Microscopy, Confocal | 6 | 2017 | 1973 | 0.380 |
Why?
|
| Apoptosis Regulatory Proteins | 6 | 2021 | 1151 | 0.380 |
Why?
|
| Membrane Proteins | 11 | 2016 | 7885 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 4 | 2017 | 637 | 0.370 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 1313 | 0.370 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2011 | 64 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-vav | 7 | 2006 | 91 | 0.370 |
Why?
|
| Professional Autonomy | 1 | 2012 | 172 | 0.370 |
Why?
|
| Carrier Proteins | 6 | 2006 | 4939 | 0.370 |
Why?
|
| Stress, Physiological | 2 | 2016 | 1408 | 0.370 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 3836 | 0.370 |
Why?
|
| Mutation | 28 | 2024 | 30266 | 0.360 |
Why?
|
| Mice, Inbred NOD | 4 | 2020 | 1839 | 0.360 |
Why?
|
| Transforming Growth Factor beta | 3 | 2020 | 2004 | 0.360 |
Why?
|
| Phosphotyrosine | 18 | 1996 | 458 | 0.350 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 1999 | 492 | 0.350 |
Why?
|
| Oncogene Proteins | 6 | 2021 | 718 | 0.350 |
Why?
|
| Cell Adhesion Molecules | 8 | 2012 | 1614 | 0.350 |
Why?
|
| Glutamic Acid | 1 | 2016 | 1191 | 0.350 |
Why?
|
| Tumor Cells, Cultured | 14 | 2014 | 6131 | 0.350 |
Why?
|
| Genes, erbB-2 | 2 | 2014 | 162 | 0.350 |
Why?
|
| Female | 61 | 2024 | 397515 | 0.340 |
Why?
|
| Mice, SCID | 3 | 2020 | 2631 | 0.340 |
Why?
|
| Cell Cycle Proteins | 14 | 2020 | 3450 | 0.340 |
Why?
|
| Microdissection | 1 | 2010 | 150 | 0.340 |
Why?
|
| Cell Biology | 1 | 2010 | 92 | 0.340 |
Why?
|
| Neoplasm Seeding | 1 | 2009 | 85 | 0.330 |
Why?
|
| Protein Kinase C | 3 | 2006 | 1207 | 0.330 |
Why?
|
| Genes, Viral | 15 | 1987 | 655 | 0.330 |
Why?
|
| Stem Cells | 3 | 2023 | 3539 | 0.330 |
Why?
|
| Cells, Cultured | 26 | 2020 | 19023 | 0.320 |
Why?
|
| Thinking | 1 | 2012 | 320 | 0.320 |
Why?
|
| Professional Competence | 1 | 2012 | 430 | 0.320 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2009 | 55 | 0.320 |
Why?
|
| Cellular Structures | 1 | 2008 | 9 | 0.320 |
Why?
|
| Actins | 12 | 2011 | 2065 | 0.320 |
Why?
|
| Collagen | 6 | 2009 | 2646 | 0.310 |
Why?
|
| Stochastic Processes | 1 | 2010 | 360 | 0.310 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 3433 | 0.310 |
Why?
|
| Neoplasm Invasiveness | 9 | 2014 | 3629 | 0.310 |
Why?
|
| Protein Isoforms | 6 | 2012 | 1714 | 0.310 |
Why?
|
| Protein Binding | 15 | 2018 | 9344 | 0.310 |
Why?
|
| Retroviridae Proteins | 6 | 1987 | 94 | 0.300 |
Why?
|
| RNA, Messenger | 13 | 2021 | 12806 | 0.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2010 | 2893 | 0.300 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 1943 | 0.300 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2009 | 260 | 0.290 |
Why?
|
| Muscle Contraction | 1 | 2012 | 1209 | 0.290 |
Why?
|
| Transcription Factors | 13 | 2020 | 12174 | 0.290 |
Why?
|
| Proteins | 11 | 2020 | 6011 | 0.280 |
Why?
|
| Autocrine Communication | 2 | 2007 | 168 | 0.280 |
Why?
|
| Neurons | 12 | 2018 | 9519 | 0.280 |
Why?
|
| Receptors, IgE | 4 | 1997 | 375 | 0.280 |
Why?
|
| Proteomics | 5 | 2022 | 3914 | 0.280 |
Why?
|
| Molecular Biology | 1 | 2010 | 573 | 0.280 |
Why?
|
| Receptor, Notch1 | 1 | 2010 | 520 | 0.270 |
Why?
|
| Gene Expression Profiling | 9 | 2016 | 9549 | 0.270 |
Why?
|
| Basement Membrane | 2 | 2004 | 348 | 0.270 |
Why?
|
| Amino Acid Sequence | 29 | 2010 | 13427 | 0.270 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 18354 | 0.270 |
Why?
|
| RNA Interference | 6 | 2018 | 2835 | 0.260 |
Why?
|
| Cyclin D1 | 4 | 2018 | 453 | 0.260 |
Why?
|
| Immunoblotting | 8 | 2016 | 1647 | 0.260 |
Why?
|
| src Homology Domains | 7 | 2003 | 361 | 0.260 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2007 | 122 | 0.260 |
Why?
|
| Receptors, Estrogen | 2 | 2016 | 2252 | 0.260 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 9 | 2009 | 185 | 0.250 |
Why?
|
| Genes, ras | 6 | 2017 | 665 | 0.250 |
Why?
|
| Cell Differentiation | 14 | 2020 | 11684 | 0.250 |
Why?
|
| Antigens, CD | 6 | 2016 | 4032 | 0.250 |
Why?
|
| Nuclear Proteins | 7 | 2020 | 5804 | 0.250 |
Why?
|
| Carcinoma | 4 | 2015 | 2340 | 0.240 |
Why?
|
| Macrophage-1 Antigen | 1 | 2006 | 286 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 2000 | 205 | 0.240 |
Why?
|
| S Phase | 2 | 2005 | 424 | 0.240 |
Why?
|
| Cell Death | 2 | 2008 | 1682 | 0.240 |
Why?
|
| Platelet Adhesiveness | 5 | 2002 | 154 | 0.230 |
Why?
|
| Platelet Activation | 6 | 2002 | 644 | 0.230 |
Why?
|
| Alpharetrovirus | 8 | 1980 | 29 | 0.230 |
Why?
|
| Cell Cycle | 6 | 2023 | 2937 | 0.230 |
Why?
|
| G1 Phase | 1 | 2005 | 403 | 0.220 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 2055 | 0.220 |
Why?
|
| Mitochondria | 2 | 2021 | 3682 | 0.220 |
Why?
|
| Blotting, Western | 6 | 2016 | 5033 | 0.220 |
Why?
|
| Research | 2 | 2010 | 1981 | 0.220 |
Why?
|
| Adenosine Triphosphate | 5 | 2011 | 2003 | 0.220 |
Why?
|
| Laminin | 3 | 2017 | 406 | 0.220 |
Why?
|
| Microfilament Proteins | 2 | 2007 | 1135 | 0.220 |
Why?
|
| Oxidation-Reduction | 3 | 2021 | 2226 | 0.210 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2012 | 384 | 0.210 |
Why?
|
| Fallopian Tubes | 1 | 2023 | 179 | 0.210 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2009 | 957 | 0.210 |
Why?
|
| GTPase-Activating Proteins | 6 | 2016 | 469 | 0.210 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2003 | 201 | 0.210 |
Why?
|
| Chick Embryo | 18 | 1992 | 975 | 0.210 |
Why?
|
| Receptors, IgG | 1 | 2006 | 564 | 0.200 |
Why?
|
| Reactive Oxygen Species | 4 | 2021 | 2149 | 0.200 |
Why?
|
| Molecular Sequence Data | 24 | 2010 | 17629 | 0.200 |
Why?
|
| Loss of Heterozygosity | 1 | 2024 | 663 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2006 | 1246 | 0.200 |
Why?
|
| Time-Lapse Imaging | 2 | 2012 | 194 | 0.190 |
Why?
|
| Aging | 1 | 2020 | 8745 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2016 | 2474 | 0.190 |
Why?
|
| Pyrimidinones | 1 | 2024 | 386 | 0.190 |
Why?
|
| Forecasting | 1 | 2010 | 2945 | 0.190 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 2008 | 187 | 0.190 |
Why?
|
| Ascites | 2 | 2020 | 338 | 0.190 |
Why?
|
| Peritoneal Neoplasms | 2 | 2020 | 714 | 0.190 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 2542 | 0.180 |
Why?
|
| Quinazolines | 2 | 2021 | 1373 | 0.180 |
Why?
|
| Peptides | 8 | 2003 | 4353 | 0.180 |
Why?
|
| Proteome | 1 | 2011 | 1891 | 0.180 |
Why?
|
| Glycolysis | 2 | 2017 | 838 | 0.180 |
Why?
|
| Fibrinogen | 11 | 2002 | 892 | 0.180 |
Why?
|
| Integrin alpha5beta1 | 2 | 2011 | 36 | 0.180 |
Why?
|
| Genes | 9 | 1987 | 1824 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2714 | 0.170 |
Why?
|
| Ligands | 6 | 2020 | 3283 | 0.170 |
Why?
|
| Drug Design | 2 | 1997 | 1046 | 0.170 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 803 | 0.170 |
Why?
|
| Cell Division | 10 | 2014 | 4478 | 0.170 |
Why?
|
| DNA-Binding Proteins | 6 | 2022 | 9618 | 0.160 |
Why?
|
| Buthionine Sulfoximine | 1 | 2019 | 17 | 0.160 |
Why?
|
| Phenotype | 9 | 2020 | 16731 | 0.160 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 23 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2023 | 569 | 0.160 |
Why?
|
| Protein Biosynthesis | 8 | 2010 | 2094 | 0.160 |
Why?
|
| Genetic Techniques | 2 | 2021 | 428 | 0.160 |
Why?
|
| Ubiquitinated Proteins | 1 | 2019 | 32 | 0.160 |
Why?
|
| Thiocyanates | 1 | 2019 | 70 | 0.160 |
Why?
|
| PDZ Domains | 1 | 2018 | 23 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 4 | 2011 | 478 | 0.160 |
Why?
|
| Transplantation, Heterologous | 2 | 2021 | 2395 | 0.160 |
Why?
|
| COS Cells | 6 | 2004 | 1135 | 0.160 |
Why?
|
| Interleukin-6 | 2 | 2007 | 3232 | 0.160 |
Why?
|
| Cell Growth Processes | 3 | 2009 | 381 | 0.160 |
Why?
|
| Biomedical Research | 2 | 2012 | 3463 | 0.160 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 6 | 2002 | 577 | 0.160 |
Why?
|
| Platelet Aggregation | 6 | 1994 | 769 | 0.160 |
Why?
|
| Pyridones | 1 | 2024 | 819 | 0.160 |
Why?
|
| Proto-Oncogenes | 3 | 1990 | 322 | 0.150 |
Why?
|
| Focal Adhesion Kinase 1 | 7 | 2009 | 120 | 0.150 |
Why?
|
| eIF-2 Kinase | 1 | 2019 | 147 | 0.150 |
Why?
|
| Mice, Nude | 2 | 2019 | 3631 | 0.150 |
Why?
|
| Molecular Weight | 17 | 1990 | 2173 | 0.150 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2002 | 342 | 0.150 |
Why?
|
| Myofibrils | 1 | 1998 | 143 | 0.150 |
Why?
|
| Genomic Instability | 2 | 2015 | 715 | 0.150 |
Why?
|
| Heterozygote | 1 | 2024 | 2798 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1997 | 434 | 0.150 |
Why?
|
| Vacuoles | 2 | 2008 | 224 | 0.140 |
Why?
|
| Ecosystem | 1 | 2022 | 494 | 0.140 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2017 | 61 | 0.140 |
Why?
|
| Phosphotransferases | 5 | 1995 | 302 | 0.140 |
Why?
|
| Integrin beta Chains | 2 | 2010 | 115 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2020 | 1064 | 0.140 |
Why?
|
| Retroviridae | 3 | 2005 | 849 | 0.140 |
Why?
|
| Integrin beta4 | 1 | 2017 | 29 | 0.140 |
Why?
|
| Protein Array Analysis | 2 | 2020 | 400 | 0.140 |
Why?
|
| Glucose | 4 | 2011 | 4352 | 0.140 |
Why?
|
| Centrosome | 2 | 2019 | 210 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2010 | 2812 | 0.140 |
Why?
|
| Transcription, Genetic | 6 | 2021 | 7609 | 0.140 |
Why?
|
| Drosophila Proteins | 4 | 2011 | 1712 | 0.140 |
Why?
|
| Melanoma | 1 | 2015 | 5709 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2021 | 4148 | 0.140 |
Why?
|
| Catalytic Domain | 1 | 2019 | 699 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1769 | 0.130 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2016 | 50 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2016 | 2942 | 0.130 |
Why?
|
| Serine | 1 | 2000 | 831 | 0.130 |
Why?
|
| Gene Expression | 7 | 2023 | 7603 | 0.130 |
Why?
|
| Nitrogen Isotopes | 1 | 2016 | 83 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2022 | 1902 | 0.130 |
Why?
|
| Cell Line, Transformed | 6 | 2003 | 867 | 0.130 |
Why?
|
| Cell Membrane | 8 | 2004 | 3659 | 0.130 |
Why?
|
| HeLa Cells | 2 | 2016 | 3076 | 0.130 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1887 | 0.130 |
Why?
|
| rho-Associated Kinases | 2 | 2008 | 285 | 0.130 |
Why?
|
| Trans-Activators | 4 | 2010 | 2858 | 0.130 |
Why?
|
| Enzyme Inhibitors | 6 | 2007 | 3726 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 4 | 2017 | 2635 | 0.130 |
Why?
|
| Gene Amplification | 1 | 2020 | 1099 | 0.130 |
Why?
|
| Systems Biology | 2 | 2017 | 482 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-yes | 5 | 2009 | 17 | 0.130 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 371 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4592 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2016 | 237 | 0.130 |
Why?
|
| Cell Physiological Phenomena | 1 | 1997 | 152 | 0.130 |
Why?
|
| Homeostasis | 2 | 2017 | 3347 | 0.120 |
Why?
|
| Transaminases | 1 | 2016 | 199 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2008 | 3591 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2012 | 1575 | 0.120 |
Why?
|
| Cell-Matrix Junctions | 1 | 2014 | 21 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1629 | 0.120 |
Why?
|
| CDC2 Protein Kinase | 1 | 2016 | 212 | 0.120 |
Why?
|
| Contractile Proteins | 1 | 2016 | 240 | 0.120 |
Why?
|
| Viper Venoms | 1 | 1994 | 16 | 0.120 |
Why?
|
| Cell Separation | 1 | 2020 | 1728 | 0.120 |
Why?
|
| Aminopyridines | 1 | 2019 | 580 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 5 | 2010 | 3775 | 0.120 |
Why?
|
| Lipoproteins | 1 | 1999 | 880 | 0.120 |
Why?
|
| Antigens, Polyomavirus Transforming | 3 | 1993 | 257 | 0.120 |
Why?
|
| Crotalid Venoms | 1 | 1994 | 29 | 0.120 |
Why?
|
| Nerve Growth Factors | 3 | 1992 | 564 | 0.120 |
Why?
|
| RNA Helicases | 1 | 1995 | 144 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 2 | 2010 | 874 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 3 | 2021 | 2909 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2019 | 2732 | 0.120 |
Why?
|
| Endocytosis | 3 | 2005 | 959 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22379 | 0.120 |
Why?
|
| Homeodomain Proteins | 3 | 2014 | 2431 | 0.120 |
Why?
|
| Alprostadil | 1 | 1994 | 86 | 0.120 |
Why?
|
| Immunotherapy | 3 | 2022 | 4756 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 3 | 2007 | 1083 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 5 | 1994 | 114 | 0.110 |
Why?
|
| Lymphocytes | 2 | 2020 | 2614 | 0.110 |
Why?
|
| Wound Healing | 3 | 2012 | 2815 | 0.110 |
Why?
|
| Sarcoma, Experimental | 5 | 1980 | 117 | 0.110 |
Why?
|
| Fibronectins | 3 | 2011 | 724 | 0.110 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1386 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2007 | 4356 | 0.110 |
Why?
|
| RNA | 1 | 2023 | 2727 | 0.110 |
Why?
|
| Immediate-Early Proteins | 2 | 1995 | 444 | 0.110 |
Why?
|
| History, 20th Century | 2 | 2012 | 2771 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 3 | 2017 | 1356 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 3744 | 0.110 |
Why?
|
| Aspartic Acid | 1 | 1995 | 577 | 0.110 |
Why?
|
| Disease Progression | 5 | 2014 | 13674 | 0.110 |
Why?
|
| Diphenylamine | 1 | 2012 | 49 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2019 | 1913 | 0.100 |
Why?
|
| Catenins | 1 | 2012 | 44 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2013 | 165 | 0.100 |
Why?
|
| Cytoplasm | 5 | 2003 | 1505 | 0.100 |
Why?
|
| Chromatin | 1 | 2024 | 2981 | 0.100 |
Why?
|
| Contact Inhibition | 2 | 2012 | 46 | 0.100 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 163 | 0.100 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 664 | 0.100 |
Why?
|
| Microscopy, Electron | 3 | 2008 | 2560 | 0.100 |
Why?
|
| Phorbol Esters | 1 | 1992 | 109 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 489 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2013 | 2960 | 0.100 |
Why?
|
| Cell Size | 2 | 2004 | 626 | 0.100 |
Why?
|
| Arginine | 1 | 1995 | 932 | 0.100 |
Why?
|
| Blood Proteins | 3 | 2011 | 1191 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9442 | 0.100 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.090 |
Why?
|
| Talin | 1 | 2011 | 47 | 0.090 |
Why?
|
| Neutrophils | 1 | 2004 | 3785 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 1658 | 0.090 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1992 | 318 | 0.090 |
Why?
|
| GTP-Binding Proteins | 5 | 1998 | 947 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 8 | 1993 | 1731 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2013 | 201 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2011 | 1752 | 0.090 |
Why?
|
| Peritoneal Cavity | 1 | 2011 | 135 | 0.090 |
Why?
|
| DNA, Complementary | 3 | 2006 | 1990 | 0.090 |
Why?
|
| Time Factors | 5 | 2021 | 40261 | 0.090 |
Why?
|
| Drosophila melanogaster | 2 | 2011 | 1726 | 0.090 |
Why?
|
| Myosins | 1 | 2012 | 408 | 0.090 |
Why?
|
| Aneuploidy | 2 | 2014 | 573 | 0.090 |
Why?
|
| Cell Surface Extensions | 1 | 2011 | 66 | 0.090 |
Why?
|
| Mitosis | 2 | 2019 | 1181 | 0.090 |
Why?
|
| Plasmids | 7 | 2003 | 2269 | 0.090 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2010 | 110 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 13594 | 0.090 |
Why?
|
| 3T3 Cells | 5 | 1995 | 1085 | 0.090 |
Why?
|
| Phosphopeptides | 6 | 1991 | 240 | 0.090 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 205 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2011 | 2525 | 0.090 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 234 | 0.090 |
Why?
|
| Intercellular Junctions | 1 | 1990 | 198 | 0.090 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2009 | 48 | 0.090 |
Why?
|
| Peritoneum | 1 | 2011 | 231 | 0.090 |
Why?
|
| Biotechnology | 1 | 2012 | 283 | 0.090 |
Why?
|
| DNA | 4 | 2017 | 7214 | 0.090 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2014 | 246 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2008 | 440 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 474 | 0.080 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2009 | 56 | 0.080 |
Why?
|
| Peptide Mapping | 4 | 1992 | 260 | 0.080 |
Why?
|
| Transfection | 6 | 2008 | 5763 | 0.080 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2010 | 132 | 0.080 |
Why?
|
| Proteoglycans | 2 | 2003 | 809 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2014 | 542 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1987 | 153 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2748 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2010 | 196 | 0.080 |
Why?
|
| Cricetinae | 11 | 2003 | 2423 | 0.080 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2009 | 41 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2018 | 14484 | 0.080 |
Why?
|
| RNA Caps | 1 | 2009 | 73 | 0.080 |
Why?
|
| MAP Kinase Kinase 1 | 3 | 2004 | 331 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 356 | 0.080 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2009 | 126 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6320 | 0.080 |
Why?
|
| Dimerization | 2 | 2001 | 886 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 1447 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 763 | 0.080 |
Why?
|
| Protein Stability | 1 | 2010 | 580 | 0.080 |
Why?
|
| Leukocytes | 1 | 1997 | 2034 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2009 | 506 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2008 | 72 | 0.080 |
Why?
|
| Binding Sites | 8 | 2002 | 6023 | 0.080 |
Why?
|
| Receptors, Fc | 1 | 1992 | 538 | 0.080 |
Why?
|
| Embryo, Mammalian | 4 | 2007 | 1676 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 558 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3671 | 0.080 |
Why?
|
| Calcium | 4 | 2003 | 5792 | 0.080 |
Why?
|
| Phenylalanine | 1 | 1990 | 368 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 2 | 2024 | 524 | 0.070 |
Why?
|
| Chickens | 5 | 1991 | 845 | 0.070 |
Why?
|
| Cell Fusion | 1 | 2008 | 294 | 0.070 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2007 | 66 | 0.070 |
Why?
|
| Fatty Acids | 2 | 2021 | 1812 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 874 | 0.070 |
Why?
|
| Base Sequence | 8 | 2003 | 12430 | 0.070 |
Why?
|
| Mast Cells | 1 | 1995 | 1406 | 0.070 |
Why?
|
| Antigens, Viral | 6 | 1978 | 996 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2010 | 3048 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2005 | 317 | 0.070 |
Why?
|
| Polyomavirus | 2 | 1987 | 235 | 0.070 |
Why?
|
| Carbonic Anhydrases | 1 | 2007 | 108 | 0.070 |
Why?
|
| Endosomes | 1 | 2010 | 525 | 0.070 |
Why?
|
| Receptors, Cell Surface | 4 | 2000 | 2820 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1995 | 706 | 0.070 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1987 | 107 | 0.070 |
Why?
|
| bcl-Associated Death Protein | 1 | 2007 | 102 | 0.070 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 88 | 0.070 |
Why?
|
| DNA Damage | 3 | 2022 | 2472 | 0.070 |
Why?
|
| Benzamides | 1 | 2012 | 1387 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4290 | 0.070 |
Why?
|
| Macrophages | 2 | 2020 | 5801 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 997 | 0.070 |
Why?
|
| Caspases | 2 | 2007 | 881 | 0.070 |
Why?
|
| Cell Hypoxia | 2 | 2007 | 662 | 0.070 |
Why?
|
| Phospholipases | 1 | 1986 | 75 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1675 | 0.070 |
Why?
|
| Lysosomes | 2 | 2013 | 940 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2003 | 2089 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2905 | 0.070 |
Why?
|
| Janus Kinases | 1 | 2007 | 253 | 0.070 |
Why?
|
| Antigens, Neoplasm | 3 | 2007 | 2001 | 0.070 |
Why?
|
| Quinolines | 1 | 2012 | 772 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2012 | 1966 | 0.060 |
Why?
|
| Imidazoles | 1 | 2012 | 1169 | 0.060 |
Why?
|
| Mimosine | 1 | 2005 | 7 | 0.060 |
Why?
|
| Phospholipases A | 1 | 1986 | 204 | 0.060 |
Why?
|
| Aphidicolin | 1 | 2005 | 37 | 0.060 |
Why?
|
| Rats | 12 | 2005 | 23786 | 0.060 |
Why?
|
| Brain Chemistry | 2 | 1991 | 959 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2007 | 2018 | 0.060 |
Why?
|
| Cloning, Molecular | 4 | 1999 | 4168 | 0.060 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2006 | 163 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 3200 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2005 | 45 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 411 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 2666 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1987 | 329 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3810 | 0.060 |
Why?
|
| Terminator Regions, Genetic | 1 | 1984 | 26 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 751 | 0.060 |
Why?
|
| Hippocampus | 1 | 2017 | 3782 | 0.060 |
Why?
|
| Carcinoma, Lobular | 1 | 2009 | 480 | 0.060 |
Why?
|
| Growth Cones | 1 | 2005 | 117 | 0.060 |
Why?
|
| Glycoproteins | 2 | 2009 | 2202 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-abl | 2 | 1995 | 145 | 0.060 |
Why?
|
| Thiazoles | 2 | 2009 | 1542 | 0.060 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1984 | 74 | 0.060 |
Why?
|
| Lentivirus | 2 | 2021 | 518 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 1197 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 379 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 1625 | 0.060 |
Why?
|
| CHO Cells | 6 | 2003 | 1379 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 945 | 0.060 |
Why?
|
| Thrombasthenia | 2 | 1993 | 21 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4300 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 826 | 0.060 |
Why?
|
| GRB2 Adaptor Protein | 3 | 1999 | 101 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 2204 | 0.050 |
Why?
|
| Puberty | 1 | 2007 | 501 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 1984 | 373 | 0.050 |
Why?
|
| Frizzled Receptors | 1 | 2023 | 91 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2003 | 247 | 0.050 |
Why?
|
| Simian virus 40 | 4 | 1977 | 292 | 0.050 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 195 | 0.050 |
Why?
|
| ras Proteins | 2 | 1999 | 1058 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2007 | 751 | 0.050 |
Why?
|
| Codon | 1 | 1984 | 599 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 424 | 0.050 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2002 | 110 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 8 | 2023 | 9264 | 0.050 |
Why?
|
| Sarcoma, Avian | 2 | 1981 | 3 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 1999 | 120 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 192 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2003 | 6232 | 0.050 |
Why?
|
| Pregnancy | 2 | 2022 | 30265 | 0.050 |
Why?
|
| Dogs | 2 | 2010 | 3845 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 710 | 0.050 |
Why?
|
| Neural Crest | 1 | 1984 | 278 | 0.050 |
Why?
|
| Middle Aged | 7 | 2024 | 223737 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2004 | 660 | 0.050 |
Why?
|
| Lasers | 1 | 2005 | 952 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2003 | 10765 | 0.050 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2001 | 69 | 0.050 |
Why?
|
| Substrate Specificity | 5 | 2002 | 1751 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2005 | 906 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2003 | 2749 | 0.050 |
Why?
|
| Prognosis | 5 | 2016 | 30046 | 0.050 |
Why?
|
| PC12 Cells | 4 | 1995 | 317 | 0.040 |
Why?
|
| Dextrans | 1 | 2002 | 574 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 1993 | 435 | 0.040 |
Why?
|
| Drosophila | 1 | 2008 | 1513 | 0.040 |
Why?
|
| Lymphokines | 2 | 1995 | 927 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2002 | 628 | 0.040 |
Why?
|
| Structure-Activity Relationship | 3 | 1995 | 3057 | 0.040 |
Why?
|
| Adult | 6 | 2024 | 223851 | 0.040 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2021 | 134 | 0.040 |
Why?
|
| Paxillin | 2 | 1997 | 86 | 0.040 |
Why?
|
| Axons | 1 | 1988 | 1678 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2004 | 567 | 0.040 |
Why?
|
| Glutathione Transferase | 3 | 2003 | 564 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2003 | 4794 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2003 | 682 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6547 | 0.040 |
Why?
|
| Peptide Fragments | 6 | 1996 | 5151 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2004 | 967 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 2023 | 725 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2000 | 127 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 1995 | 458 | 0.040 |
Why?
|
| Temperature | 7 | 1992 | 2235 | 0.040 |
Why?
|
| Cerebellum | 1 | 1987 | 1522 | 0.040 |
Why?
|
| Anaphase | 1 | 2019 | 112 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2830 | 0.040 |
Why?
|
| DNA Replication | 2 | 2022 | 1428 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2019 | 190 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 859 | 0.040 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 1998 | 73 | 0.040 |
Why?
|
| Annexins | 2 | 1990 | 40 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2005 | 1093 | 0.040 |
Why?
|
| Protein Transport | 1 | 2004 | 1956 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 405 | 0.040 |
Why?
|
| Myristic Acid | 2 | 1988 | 49 | 0.040 |
Why?
|
| Myristic Acids | 2 | 1988 | 49 | 0.040 |
Why?
|
| Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2004 | 925 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1081 | 0.040 |
Why?
|
| Brain | 7 | 2017 | 27453 | 0.040 |
Why?
|
| Kinetochores | 1 | 2019 | 172 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2019 | 223 | 0.040 |
Why?
|
| Synapsins | 1 | 2017 | 43 | 0.040 |
Why?
|
| Precipitin Tests | 3 | 2003 | 816 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 41808 | 0.040 |
Why?
|
| Synaptophysin | 1 | 2017 | 138 | 0.040 |
Why?
|
| Chromones | 1 | 1997 | 148 | 0.040 |
Why?
|
| Rabbits | 6 | 1990 | 4774 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2007 | 1893 | 0.040 |
Why?
|
| Polylysine | 1 | 1997 | 131 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 1769 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2005 | 2492 | 0.030 |
Why?
|
| Insulin | 1 | 2011 | 6610 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 315 | 0.030 |
Why?
|
| Intestines | 1 | 2005 | 1911 | 0.030 |
Why?
|
| Sirolimus | 1 | 2003 | 1540 | 0.030 |
Why?
|
| Starvation | 1 | 2017 | 141 | 0.030 |
Why?
|
| Cytochalasin D | 2 | 1993 | 91 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2010 | 6291 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1987 | 2682 | 0.030 |
Why?
|
| Neurites | 2 | 1995 | 390 | 0.030 |
Why?
|
| Phosphoserine | 2 | 1989 | 204 | 0.030 |
Why?
|
| Early Growth Response Protein 1 | 2 | 1995 | 133 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2000 | 1229 | 0.030 |
Why?
|
| Biological Transport | 3 | 1993 | 2085 | 0.030 |
Why?
|
| Receptors, Thrombin | 1 | 1996 | 130 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 2007 | 3412 | 0.030 |
Why?
|
| Tacrolimus | 1 | 1999 | 750 | 0.030 |
Why?
|
| Androstadienes | 1 | 1997 | 348 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1995 | 69 | 0.030 |
Why?
|
| Leukemia, Basophilic, Acute | 1 | 1995 | 15 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 2067 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 428 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 789 | 0.030 |
Why?
|
| I-kappa B Kinase | 2 | 2007 | 250 | 0.030 |
Why?
|
| Aged | 4 | 2024 | 171786 | 0.030 |
Why?
|
| Receptors, Cytoadhesin | 1 | 1994 | 8 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 2 | 1989 | 4413 | 0.030 |
Why?
|
| Ovary | 2 | 2011 | 965 | 0.030 |
Why?
|
| Kinetics | 5 | 1996 | 6332 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 724 | 0.030 |
Why?
|
| Disintegrins | 1 | 1994 | 27 | 0.030 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1994 | 58 | 0.030 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1994 | 64 | 0.030 |
Why?
|
| Triazoles | 1 | 2020 | 904 | 0.030 |
Why?
|
| Computational Biology | 2 | 2020 | 3562 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2003 | 2885 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2016 | 332 | 0.030 |
Why?
|
| Thromboxane A2 | 1 | 1994 | 87 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1994 | 166 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 598 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 2 | 1996 | 835 | 0.030 |
Why?
|
| Morpholines | 1 | 1997 | 584 | 0.030 |
Why?
|
| Actomyosin | 1 | 2014 | 114 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2002 | 1703 | 0.030 |
Why?
|
| CA-125 Antigen | 1 | 2016 | 281 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2020 | 1406 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2002 | 128 | 0.030 |
Why?
|
| Vinculin | 1 | 1993 | 59 | 0.030 |
Why?
|
| Maleimides | 1 | 1994 | 112 | 0.030 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1994 | 95 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 812 | 0.030 |
Why?
|
| Proline | 1 | 1995 | 455 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2002 | 1682 | 0.030 |
Why?
|
| Indomethacin | 1 | 1994 | 323 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 618 | 0.030 |
Why?
|
| Leupeptins | 1 | 2013 | 113 | 0.030 |
Why?
|
| Leukotrienes | 1 | 1995 | 232 | 0.030 |
Why?
|
| Octoxynol | 1 | 1993 | 76 | 0.030 |
Why?
|
| Spectrin | 1 | 1993 | 176 | 0.030 |
Why?
|
| Leukemia, Hairy Cell | 1 | 1993 | 82 | 0.030 |
Why?
|
| Vaccinia virus | 1 | 1995 | 330 | 0.030 |
Why?
|
| Cytokines | 3 | 2005 | 7453 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 60131 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 898 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 1995 | 359 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1762 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1995 | 674 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 719 | 0.030 |
Why?
|
| Immunologic Techniques | 4 | 1987 | 213 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 1995 | 385 | 0.030 |
Why?
|
| Antibodies, Viral | 3 | 1979 | 3215 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1994 | 446 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2012 | 43 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1993 | 383 | 0.020 |
Why?
|
| Cyanogen Bromide | 1 | 1991 | 75 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4428 | 0.020 |
Why?
|
| Chemokines | 2 | 2007 | 963 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 1986 | 1435 | 0.020 |
Why?
|
| Retina | 2 | 2017 | 2661 | 0.020 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1992 | 176 | 0.020 |
Why?
|
| Protein Conformation | 3 | 1994 | 3956 | 0.020 |
Why?
|
| Entosis | 1 | 2011 | 5 | 0.020 |
Why?
|
| Apyrase | 1 | 1994 | 376 | 0.020 |
Why?
|
| Bacteriophages | 1 | 1994 | 382 | 0.020 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2011 | 42 | 0.020 |
Why?
|
| Solubility | 1 | 1993 | 1087 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 1992 | 422 | 0.020 |
Why?
|
| Growth Substances | 1 | 1993 | 760 | 0.020 |
Why?
|
| Tropomyosin | 1 | 2011 | 106 | 0.020 |
Why?
|
| Immune Sera | 3 | 1990 | 605 | 0.020 |
Why?
|
| Epinephrine | 1 | 1994 | 794 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6401 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 1991 | 375 | 0.020 |
Why?
|
| Receptors, Invertebrate Peptide | 1 | 2009 | 13 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 2 | 1990 | 513 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20245 | 0.020 |
Why?
|
| Immunosorbent Techniques | 2 | 1987 | 174 | 0.020 |
Why?
|
| Phospholipase D | 1 | 2010 | 70 | 0.020 |
Why?
|
| Interleukins | 1 | 1995 | 796 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 1992 | 577 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2003 | 4076 | 0.020 |
Why?
|
| Receptor, EphA2 | 1 | 2009 | 41 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1994 | 990 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 1992 | 1216 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 1680 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 3408 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1933 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2009 | 167 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2013 | 915 | 0.020 |
Why?
|
| Cisplatin | 1 | 2015 | 1661 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1994 | 1194 | 0.020 |
Why?
|
| Connexins | 1 | 1990 | 355 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1524 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2009 | 466 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 859 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2013 | 1010 | 0.020 |
Why?
|
| Microtubules | 1 | 2014 | 1062 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2013 | 1866 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2015 | 1735 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2024 | 65480 | 0.020 |
Why?
|
| Pyrazines | 1 | 2013 | 1206 | 0.020 |
Why?
|
| Autoradiography | 1 | 1988 | 728 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2008 | 189 | 0.020 |
Why?
|
| Muscles | 1 | 1992 | 1582 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 1197 | 0.020 |
Why?
|
| Vanadium | 1 | 1987 | 54 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 2087 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1320 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2002 | 4850 | 0.020 |
Why?
|
| Research Design | 1 | 2002 | 6214 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1993 | 945 | 0.020 |
Why?
|
| Reference Values | 1 | 1993 | 4940 | 0.020 |
Why?
|
| Myristates | 1 | 1986 | 12 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 1986 | 197 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 1987 | 438 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10276 | 0.020 |
Why?
|
| Kidney | 1 | 2001 | 7058 | 0.020 |
Why?
|
| Indoles | 1 | 1994 | 1836 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1904 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 1991 | 873 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 1992 | 1506 | 0.020 |
Why?
|
| Exons | 1 | 1991 | 2395 | 0.020 |
Why?
|
| Ephrins | 1 | 2005 | 28 | 0.020 |
Why?
|
| Male | 4 | 2024 | 365203 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2005 | 177 | 0.020 |
Why?
|
| Cell Shape | 1 | 2006 | 371 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 897 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 210 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 9565 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3335 | 0.010 |
Why?
|
| Adenoviridae | 2 | 2007 | 1095 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2011 | 1505 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2005 | 253 | 0.010 |
Why?
|
| United States | 2 | 2011 | 73186 | 0.010 |
Why?
|
| Thiazolidines | 1 | 2004 | 70 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 1984 | 46 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1986 | 446 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1390 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 463 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 432 | 0.010 |
Why?
|
| Chromatography | 1 | 2003 | 189 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2000 | 617 | 0.010 |
Why?
|
| Trypsin | 1 | 1984 | 491 | 0.010 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2003 | 59 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1992 | 4124 | 0.010 |
Why?
|
| Interferons | 1 | 2007 | 720 | 0.010 |
Why?
|
| Caseins | 1 | 1983 | 105 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1983 | 253 | 0.010 |
Why?
|
| Digitonin | 1 | 2002 | 25 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 6086 | 0.010 |
Why?
|
| Hybridomas | 1 | 1983 | 444 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1984 | 389 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2007 | 1970 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1994 | 2763 | 0.010 |
Why?
|
| Heat-Shock Proteins | 2 | 1985 | 797 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 2 | 2007 | 2634 | 0.010 |
Why?
|
| Cell-Free System | 2 | 1980 | 340 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 1340 | 0.010 |
Why?
|
| Mouth Neoplasms | 1 | 2007 | 597 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 59739 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1993 | 777 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2006 | 876 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1983 | 828 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1981 | 298 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 1988 | 985 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2001 | 120 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11262 | 0.010 |
Why?
|
| Gene Library | 2 | 1995 | 1062 | 0.010 |
Why?
|
| Chimera | 1 | 2002 | 454 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2011 | 3449 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 1985 | 1159 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2002 | 573 | 0.010 |
Why?
|
| Deoxyglucose | 3 | 1976 | 333 | 0.010 |
Why?
|
| Embryonal Carcinoma Stem Cells | 2 | 1992 | 20 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2010 | 5404 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2003 | 713 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1984 | 1616 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1989 | 6512 | 0.010 |
Why?
|
| Activating Transcription Factor 2 | 1 | 1999 | 44 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1992 | 4213 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2003 | 738 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5906 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2000 | 739 | 0.010 |
Why?
|
| Postmenopause | 1 | 2008 | 2519 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1979 | 530 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 1742 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 1998 | 188 | 0.010 |
Why?
|
| Transcriptional Activation | 2 | 1995 | 1750 | 0.010 |
Why?
|
| Astrocytes | 1 | 1985 | 1349 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1978 | 223 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2000 | 547 | 0.010 |
Why?
|
| Tretinoin | 2 | 1992 | 525 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1988 | 2543 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1986 | 2421 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1999 | 500 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3813 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 3629 | 0.010 |
Why?
|
| International Cooperation | 1 | 2002 | 1436 | 0.010 |
Why?
|
| Bacteriophage M13 | 1 | 1995 | 39 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1978 | 739 | 0.010 |
Why?
|
| Arvicolinae | 3 | 1980 | 21 | 0.010 |
Why?
|
| Antibodies | 2 | 1996 | 2422 | 0.010 |
Why?
|
| Cricetulus | 1 | 1997 | 812 | 0.010 |
Why?
|
| Risk | 1 | 2008 | 9621 | 0.010 |
Why?
|
| Amino Acids | 1 | 1982 | 1716 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 1515 | 0.010 |
Why?
|
| Genistein | 1 | 1995 | 87 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 5323 | 0.010 |
Why?
|
| Genomic Library | 1 | 1994 | 189 | 0.010 |
Why?
|
| Isoflavones | 1 | 1995 | 139 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1990 | 6611 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 3044 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 1683 | 0.010 |
Why?
|
| Species Specificity | 1 | 1978 | 2417 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1995 | 751 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1498 | 0.010 |
Why?
|
| Anemia, Aplastic | 1 | 1975 | 231 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1995 | 1266 | 0.010 |
Why?
|
| Point Mutation | 1 | 1997 | 1596 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 1992 | 417 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1978 | 1441 | 0.010 |
Why?
|
| Solutions | 1 | 1992 | 410 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 4064 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1992 | 238 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1991 | 81 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2179 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2000 | 2574 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1997 | 1418 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 417 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 849 | 0.010 |
Why?
|
| Internet | 1 | 2002 | 3112 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1990 | 178 | 0.010 |
Why?
|
| Keratins | 1 | 1992 | 502 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1990 | 280 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1992 | 337 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 13318 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1991 | 693 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 5801 | 0.000 |
Why?
|
| Cell Count | 1 | 1991 | 1833 | 0.000 |
Why?
|
| Databases, Factual | 1 | 2002 | 8094 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 1536 | 0.000 |
Why?
|
| Age Factors | 1 | 1983 | 18435 | 0.000 |
Why?
|
| Oviducts | 1 | 1985 | 11 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1990 | 2298 | 0.000 |
Why?
|
| Epitopes | 2 | 1985 | 2529 | 0.000 |
Why?
|
| Haplorhini | 2 | 1977 | 523 | 0.000 |
Why?
|
| Yolk Sac | 1 | 1984 | 79 | 0.000 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1993 | 1560 | 0.000 |
Why?
|
| Aspirin | 1 | 1996 | 3135 | 0.000 |
Why?
|
| Rats, Inbred F344 | 1 | 1985 | 825 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1995 | 3518 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1991 | 1965 | 0.000 |
Why?
|
| Caenorhabditis elegans | 1 | 1992 | 1469 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 1437 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3782 | 0.000 |
Why?
|
| Skin | 1 | 1975 | 4506 | 0.000 |
Why?
|
| Avian leukosis virus | 1 | 1979 | 19 | 0.000 |
Why?
|
| Plasminogen Activators | 1 | 1980 | 199 | 0.000 |
Why?
|
| Chemistry | 1 | 1979 | 327 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1979 | 486 | 0.000 |
Why?
|
| Birds | 1 | 1978 | 166 | 0.000 |
Why?
|
| Virus Replication | 2 | 1976 | 2458 | 0.000 |
Why?
|
| Agglutination | 1 | 1976 | 42 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1990 | 11116 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1976 | 190 | 0.000 |
Why?
|
| Cells | 1 | 1977 | 166 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1979 | 1135 | 0.000 |
Why?
|
| Genetic Complementation Test | 1 | 1975 | 557 | 0.000 |
Why?
|
| Surface Properties | 1 | 1975 | 1169 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1978 | 2871 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1975 | 4625 | 0.000 |
Why?
|